Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 02/29/12
Due: 02/28/13
Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
Phase: N/A
Priority: Normal
Start: 12/03/24
End: 05/31/25
Due: 05/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus | NCT01041625 | Virginia Clinical Research, Inc. | user2@example.com | None | 2010-02-28 | 2012-02-29 | 2013-02-28 | - | - | 2025-07-14 |
| Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1% | NCT06645821 | Virginia Clinical Research, Inc. | user2@example.com | None | 2024-12-03 | 2025-05-31 | 2026-05-31 | - | - | 2025-07-14 |